613 related articles for article (PubMed ID: 28182612)
1. Non-Alcoholic Fatty Liver Disease in HIV Infection.
Macías J; Pineda JA; Real LM
AIDS Rev; 2017; 19(1):35-46. PubMed ID: 28182612
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV.
Verna EC
Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):211-223. PubMed ID: 28404136
[TBL] [Abstract][Full Text] [Related]
4. Non-Alcoholic Fatty Liver Disease in Patients with HIV Infection.
Papagianni M; Tziomalos K
AIDS Rev; 2018; 20(3):171-173. PubMed ID: 30264828
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
[TBL] [Abstract][Full Text] [Related]
6. Practical approach to non-alcoholic fatty liver disease in patients with diabetes.
Tai FW; Syn WK; Alazawi W
Diabet Med; 2015 Sep; 32(9):1121-33. PubMed ID: 25683343
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease and hepatitis C infection.
Bondini S; Younossi ZM
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection.
Li Vecchi V; Soresi M; Giannitrapani L; Di Carlo P; Mazzola G; Colletti P; Terranova A; Vizzini G; Montalto G
Int J Infect Dis; 2012 May; 16(5):e397-402. PubMed ID: 22425495
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease and HIV infection.
Vallet-Pichard A; Mallet V; Pol S
Semin Liver Dis; 2012 May; 32(2):158-66. PubMed ID: 22760655
[TBL] [Abstract][Full Text] [Related]
10. Management of HCV-related end-stage liver disease in HIV-coinfected patients.
Merchante N; Jiménez-Saenz M; Pineda JA
AIDS Rev; 2007; 9(3):131-9. PubMed ID: 17982938
[TBL] [Abstract][Full Text] [Related]
11. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
[TBL] [Abstract][Full Text] [Related]
12. Chronic liver disease in the human immunodeficiency virus patient.
Acharya C; Dharel N; Sterling RK
Clin Liver Dis; 2015 Feb; 19(1):1-22. PubMed ID: 25454294
[TBL] [Abstract][Full Text] [Related]
13. Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV.
Rockstroh JK
Curr HIV/AIDS Rep; 2017 Apr; 14(2):47-53. PubMed ID: 28284005
[TBL] [Abstract][Full Text] [Related]
14. Pediatric Non-alcoholic Fatty Liver Disease.
Uppal V; Mansoor S; Furuya KN
Curr Gastroenterol Rep; 2016 May; 18(5):24. PubMed ID: 27086005
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.
Yki-Järvinen H
Lancet Diabetes Endocrinol; 2014 Nov; 2(11):901-10. PubMed ID: 24731669
[TBL] [Abstract][Full Text] [Related]
16. The diagnosis and treatment of non-alcoholic fatty liver disease.
Altinbas A; Sowa JP; Hasenberg T; Canbay A
Minerva Gastroenterol Dietol; 2015 Sep; 61(3):159-69. PubMed ID: 26080905
[TBL] [Abstract][Full Text] [Related]
17. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight.
Ballestri S; Nascimbeni F; Romagnoli D; Baldelli E; Targher G; Lonardo A
Int J Mol Sci; 2016 Mar; 17(3):355. PubMed ID: 27005620
[TBL] [Abstract][Full Text] [Related]
18. Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant.
Gitto S; Villa E
Int J Mol Sci; 2016 Apr; 17(4):490. PubMed ID: 27049380
[TBL] [Abstract][Full Text] [Related]
19. NONALCOHOLIC FATTY LIVER DISEASE AND ITS COMPLICATIONS--ASSESSING THE POPULATION AT RISK. A SMALL SERIES REPORT AND LITERATURE REVIEW.
Livadariu R; Timofte D; Danilă R; Ionescu L; Diaconu C; Soroceanu P; Sângeap AM; Drug VL; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):346-52. PubMed ID: 26204635
[TBL] [Abstract][Full Text] [Related]
20. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV.
Lonardo A; Ballestri S; Guaraldi G; Nascimbeni F; Romagnoli D; Zona S; Targher G
World J Gastroenterol; 2016 Nov; 22(44):9674-9693. PubMed ID: 27956792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
